Institutional Clinical and Translational Science Award

NIH RePORTER · NIH · UL1 · $9,938,391 · view on reporter.nih.gov ↗

Abstract

Contact PD/PI: FITZGERALD, GARRET A OVERALL ABSTRACT/SUMMARY The Institute for Translational Medicine and Therapeutics is the academic home for the CTSA in Penn. For the past decade the specific aims of ITMAT have been and remain (i) to increase the number of investigators capable of pursuing their research between proof of concept in cells and model systems and (ii) elucidation of the mechanisms of human physiology, disease or drug action through intense phenotyping in small numbers of people. The two priorities of our CTSA are to foster the field of translational therapeutics and to bridge the pediatric to adult divide across the entire spectrum of clinical and translational science. This section describes how these priorities have influenced the growth of this CTSA Hub and outlines our plans for the coming funding period. Project Summary/Abstract Page 103 Contact PD/PI: FITZGERALD, GARRET A OVERALL NARRATIVE The Institute for Translational Medicine and Therapeutics is the academic home for the CTSA in Penn. For the past decade the specific aims of ITMAT have been and remain (i) to increase the number of investigators capable of pursuing their research between proof of concept in cells and model systems and (ii) elucidation of the mechanisms of human physiology, disease or drug action through intense phenotyping in small numbers of people.

Key facts

NIH application ID
9949458
Project number
5UL1TR001878-05
Recipient
UNIVERSITY OF PENNSYLVANIA
Principal Investigator
GARRET A FITZGERALD
Activity code
UL1
Funding institute
NIH
Fiscal year
2020
Award amount
$9,938,391
Award type
5
Project period
2016-07-01 → 2021-05-31